600664 Harbin Pharmaceutical Group Co., Ltd. SSE · China

Harbin Pharmaceutical Group Co. (600664) news

Harbin Pharmaceutical Group Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600664, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Harbin Pharmaceutical Group Co. news

We have not published a story on Harbin Pharmaceutical Group Co. yet. When there is news, it will appear here.

Questions about Harbin Pharmaceutical Group Co.

What is the ticker symbol of Harbin Pharmaceutical Group Co.?

Harbin Pharmaceutical Group Co., Ltd. trades under the ticker 600664 on SSE.

Where is Harbin Pharmaceutical Group Co. listed?

Harbin Pharmaceutical Group Co., Ltd. is listed on SSE.

Which country or territory is Harbin Pharmaceutical Group Co. listed under?

Our directory records Harbin Pharmaceutical Group Co., Ltd. under China.

What does Harbin Pharmaceutical Group Co. do?

Our directory classifies Harbin Pharmaceutical Group Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Harbin Pharmaceutical Group Co.?

The ISIN recorded for Harbin Pharmaceutical Group Co., Ltd. is CNE0000009T3.

Does aibio.space cover Harbin Pharmaceutical Group Co.?

aibio.space lists Harbin Pharmaceutical Group Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Harbin Pharmaceutical Group Co.?

Companies in our directory listed in the same country and business area as Harbin Pharmaceutical Group Co.: CANbridge Pharmaceuticals, Yantai Dongcheng Biochemicals Co., Hightide Therapeutics, Changzhou Qianhong Bio-Pharma Co., Chongqing Genrix Biopharmaceutical Co., Hansoh Pharmaceutical Group Company.

Investor discussion: Harbin Pharmaceutical Group Co.

Members talk about Harbin Pharmaceutical Group Co. (600664). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600664 on TradingView.

Listing details

Company: Harbin Pharmaceutical Group Co., Ltd.
Ticker: 600664
Listing: SSE
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: CNE0000009T3
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction